Eutectic substance of donepezil and irbesartan as well as preparation method and composition of eutectic substance and applications of eutectic substance and composition

A technology of donepezil and eutectic, applied in the field of eutectic solid state form, can solve the problems of unseen donepezil and irbesartan

Active Publication Date: 2019-11-15
INST OF MATERIA MEDICA AN INST OF THE CHINESE ACAD OF MEDICAL SCI
View PDF3 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0012] In summary, there has been no research report on the formation of co-crystal or co-amorphous compound of donepezil and irbesartan so far, and there is no similarity with that of the present invention in terms of material form, material state, combination ratio, preparation method and use. Similar or Conflicting Research Content

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Eutectic substance of donepezil and irbesartan as well as preparation method and composition of eutectic substance and applications of eutectic substance and composition
  • Eutectic substance of donepezil and irbesartan as well as preparation method and composition of eutectic substance and applications of eutectic substance and composition
  • Eutectic substance of donepezil and irbesartan as well as preparation method and composition of eutectic substance and applications of eutectic substance and composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0069] Preparation method 1 of donepezil and irbesartan co-crystal:

[0070] As shown in the table below, take appropriate amounts of donepezil and irbesartan and put them into a mortar with a molar ratio of 1:1, add an appropriate amount of solvent, and manually grind for an appropriate time. It was analyzed by powder X-ray diffraction, and its diffraction pattern was consistent with that in Figure 1, indicating that the obtained sample was a cocrystal of donepezil and irbesartan.

[0071]

[0072]

[0073]Preparation method 2 of donepezil and irbesartan co-crystal:

[0074] As shown in the table below, take appropriate amounts of donepezil and irbesartan and put them into a ball mill jar at a molar ratio of 1:1, add an appropriate amount of organic solvent, select an appropriate ball-to-material ratio, set an appropriate speed, and grind for an appropriate time. Carry out powder X-ray diffraction analysis to it, its diffraction pattern and figure 1 Consistent, indica...

Embodiment 2

[0081] In Vitro Dissolution and Release Characteristics of Cocrystals of Donepezil and Irbesartan

[0082] The solubility characteristics of donepezil-irbesartan co-crystal and irbesartan bulk drug in aqueous solution and 0.5% SDS aqueous solution were investigated. Refer to the "Technical Guidelines for Dissolution Test of Ordinary Oral Solid Preparations" for determination, the model-independent similarity factor (f2) method is used for the comparison of dissolution curves, and the raw materials and physical mixtures and the co-crystals of donepezil and irbesartan are compared through the calculation of f2 values The similarity of the dissolution curves of the samples in the two solvent systems, when the f2 value is higher than 50, the two curves are considered similar, and when the f2 value is lower than 50, the two curves are considered to be different. In the experiment, the irbesartan sample was used as a reference, and the model-independent similarity factor f2 value wa...

Embodiment 3

[0089] Example 3 Donepezil and irbesartan co-crystal absorption characteristics and blood drug concentration characteristics in rats:

[0090] The metabolic characteristics of the donepezil and irbesartan co-crystals involved in the present invention include the following processes:

[0091] Nine SD rats were randomly divided into 3 groups with 3 rats in each group. No food or water was allowed 12 hours before administration. The weight of the rat was weighed, and the physical mixture of donepezil and irbesartan, the raw material of irbesartan, and the cocrystal samples of donepezil and irbesartan were packed according to the irbesartan dosage of 100 mg kg-1. Put the drug powder into the solid applicator directly into the stomach of the rat through the oral cavity. At 5 minutes, 15 minutes, 30 minutes, 45 minutes, 1 hour, 1.5 hours, 2 hours, 3 hours, 4 hours, 6 hours, 9 hours, 12 hours, and 24 hours after administration, blood was collected from the ocular vein plexus and he...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a eutectic substance (represented by a formula I) formed by a combination of donepezil and irbesartan by a non-covalent bond as well as a preparation method and a composition of the eutectic substance, and applications of the eutectic substance and the composition. Specifically, the invention discloses a solid state form of the eutectic substance formed by the donepezil andthe irbesartan, the preparation method of the eutectic substance state form formed by the donepezil and the irbesartan, and the applications of the solid substance of the eutectic substance state form formed by the donepezil and the irbesartan as a pharmaceutically active ingredient in preparation of various drugs for preventing and / or treating cardiovascular diseases such as heart failure, myocardial ischemia, hypertension, vascular diseases, angina pectoris, hyperlipemia, atherosclerosis and diabetic complications, neurodegenerative diseases such as an Alzheimer disease and complicating diseases of the above diseases.

Description

technical field [0001] The present invention relates to the discovery of a co-crystal solid state form of donepezil and irbesartan in a solid state; relates to the invention of a preparation method for the co-crystal of donepezil and irbesartan; relates to the invention of a co-crystal containing donepezil and irbesartan A sartan co-crystal or a pharmaceutical composition containing a mixed crystal of donepezil and irbesartan co-crystal in any non-zero ratio; Prevention and treatment of heart failure, myocardial ischemia, hypertension, vascular disease, angina pectoris, hyperlipidemia, atherosclerosis or diabetic nephropathy and other cardiovascular diseases and neurodegenerative diseases such as Alzheimer's disease and the complications of the above diseases application in disease medicine. Background technique [0002] Drug co-crystal refers to the crystal formed by the intermolecular non-covalent interaction force between the active drug molecule and the co-crystal ligan...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & AuthorityApplications(China)
IPC IPC(8): C07D211/32A61K31/4184A61K31/445A61P3/06A61P3/10A61P9/00A61P9/04A61P9/10A61P9/12A61P9/14A61P25/28C07D403/10
CPCC07D211/32C07D403/10A61P9/00A61P25/28A61P9/12A61P9/14A61P9/04A61P9/10A61P3/06A61P3/10C07B2200/13
Inventor杜冠华吕扬生立嵩王守宝杨世颖宋俊科杨德智何萍
OwnerINST OF MATERIA MEDICA AN INST OF THE CHINESE ACAD OF MEDICAL SCI